The United States represents the largest market for aortic and peripheral vascular interventional therapy products, driven by the high prevalence of cardiovascular diseases, peripheral artery disease (PAD), and aortic aneurysms. The country's advanced healthcare infrastructure, strong reimbursement framework, and rapid adoption of innovative minimally invasive technologies continue to support...
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek